Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

Similar articles for PubMed (Select 23245326)

1.

Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.

Love MS, Millholland MG, Mishra S, Kulkarni S, Freeman KB, Pan W, Kavash RW, Costanzo MJ, Jo H, Daly TM, Williams DR, Kowalska MA, Bergman LW, Poncz M, DeGrado WF, Sinnis P, Scott RW, Greenbaum DC.

Cell Host Microbe. 2012 Dec 13;12(6):815-23. doi: 10.1016/j.chom.2012.10.017.

2.

Small-molecule histone methyltransferase inhibitors display rapid antimalarial activity against all blood stage forms in Plasmodium falciparum.

Malmquist NA, Moss TA, Mecheri S, Scherf A, Fuchter MJ.

Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16708-13. doi: 10.1073/pnas.1205414109. Epub 2012 Sep 24.

3.

Platelet factor 4 and Duffy antigen required for platelet killing of Plasmodium falciparum.

McMorran BJ, Wieczorski L, Drysdale KE, Chan JA, Huang HM, Smith C, Mitiku C, Beeson JG, Burgio G, Foote SJ.

Science. 2012 Dec 7;338(6112):1348-51. doi: 10.1126/science.1228892.

4.

A class of potent antimalarials and their specific accumulation in infected erythrocytes.

Wengelnik K, Vidal V, Ancelin ML, Cathiard AM, Morgat JL, Kocken CH, Calas M, Herrera S, Thomas AW, Vial HJ.

Science. 2002 Feb 15;295(5558):1311-4.

5.

Beneficial effect of aurothiomalate on murine malaria.

Alesutan I, Bobbala D, Qadri SM, Estremera A, Föller M, Lang F.

Malar J. 2010 May 7;9:118. doi: 10.1186/1475-2875-9-118.

6.

[Erythrocytes infected by Plasmodium falciparum activate human platelets].

Polack B, Peyron F, Sheick Zadiuddin I, Kolodié L, Ambroise-Thomas P.

C R Acad Sci III. 1990;310(12):577-82. French.

PMID:
2142012
7.

[In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].

Touré AO, Koné LP, Jambou R, Konan TD, Demba S, Beugre GE, Koné M.

Sante. 2008 Jan-Mar;18(1):43-7. doi: 10.1684/san.2008.0103. French.

PMID:
18684691
8.

Fosmidomycin uptake into Plasmodium and Babesia-infected erythrocytes is facilitated by parasite-induced new permeability pathways.

Baumeister S, Wiesner J, Reichenberg A, Hintz M, Bietz S, Harb OS, Roos DS, Kordes M, Friesen J, Matuschewski K, Lingelbach K, Jomaa H, Seeber F.

PLoS One. 2011 May 4;6(5):e19334. doi: 10.1371/journal.pone.0019334.

9.

New targets for drug discovery against malaria.

Santos G, Torres NV.

PLoS One. 2013;8(3):e59968. doi: 10.1371/journal.pone.0059968. Epub 2013 Mar 28.

10.

The antimicrobial peptide NK-2, the core region of mammalian NK-lysin, kills intraerythrocytic Plasmodium falciparum.

Gelhaus C, Jacobs T, Andrä J, Leippe M.

Antimicrob Agents Chemother. 2008 May;52(5):1713-20. doi: 10.1128/AAC.01342-07. Epub 2008 Mar 10.

11.

Influence of paclitaxel on parasitemia and survival of Plasmodium berghei infected mice.

Koka S, Bobbala D, Lang C, Boini KM, Huber SM, Lang F.

Cell Physiol Biochem. 2009;23(1-3):191-8. doi: 10.1159/000204107. Epub 2009 Feb 18.

PMID:
19255513
12.

In vitro and in vivo inhibition of erythrocytic development of malarial parasites by docetaxel.

Sinou V, Grellier P, Schrevel J.

Antimicrob Agents Chemother. 1996 Feb;40(2):358-61.

13.

Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid.

Kasinathan RS, Föller M, Koka S, Huber SM, Lang F.

Naunyn Schmiedebergs Arch Pharmacol. 2007 Jan;374(4):255-64. Epub 2006 Dec 19.

PMID:
17180616
14.

In vitro antiplasmodium effects of dermaseptin S4 derivatives.

Dagan A, Efron L, Gaidukov L, Mor A, Ginsburg H.

Antimicrob Agents Chemother. 2002 Apr;46(4):1059-66.

15.

Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds.

Gumila C, Ancelin ML, Delort AM, Jeminet G, Vial HJ.

Antimicrob Agents Chemother. 1997 Mar;41(3):523-9. Erratum in: J Am Coll Surg 1997 Oct;185(4):423-4.

16.

Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.

Patel K, Batty KT, Moore BR, Gibbons PL, Bulitta JB, Kirkpatrick CM.

Antimicrob Agents Chemother. 2013 Jan;57(1):508-16. doi: 10.1128/AAC.01463-12. Epub 2012 Nov 12.

17.

Curcumin for malaria therapy.

Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN.

Biochem Biophys Res Commun. 2005 Jan 14;326(2):472-4.

PMID:
15582601
18.

Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol.

Sato A, Hiramoto A, Morita M, Matsumoto M, Komich Y, Nakase Y, Tanigawa N, Hiraoka O, Hiramoto K, Hayatsu H, Higaki K, Kawai S, Masuyama A, Nojima M, Wataya Y, Kim HS.

Parasitol Int. 2011 Sep;60(3):270-3. doi: 10.1016/j.parint.2011.04.001. Epub 2011 Apr 8.

PMID:
21501696
19.

Platelets kill intraerythrocytic malarial parasites and mediate survival to infection.

McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK, Corbin JE, Alexander WS, Foote SJ.

Science. 2009 Feb 6;323(5915):797-800. doi: 10.1126/science.1166296.

20.

Provitamin B5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite.

Saliba KJ, Ferru I, Kirk K.

Antimicrob Agents Chemother. 2005 Feb;49(2):632-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk